PillRx only · Tablet, Extended Release · Oral
Pramipexole Dihydrochloride
Pramipexole Dihydrochloride
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US43 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 34 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.443
Latest avg · Jul 22, 2026
-40%
Since Oct 22, 2025
7
Active US suppliers
56%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
939
Rx · 2026 Q1
38K
Units dispensed
-18%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | unknown | 14 | SUPPLYING |
| Alembic Pharmaceuticals Limited | unknown | 14 | SUPPLYING |
| Ingenus Pharmaceuticals, LLC | unknown | 7 | SUPPLYING |
| NorthStar RxLLC | unknown | 6 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 5 | SUPPLYING |
| Vitruvias Therapeutics | unknown | 2 | SUPPLYING |
| Xiamen LP Pharmaceutical Co., Ltd. | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.